This early period is called Seroconversion.
This process is called Seroconversion.
This period of time is called"Seroconversion".
In the fulminant course of HBV, very fast Seroconversion is observed
and only anti-HB s can be detected.
However, HBe Seroconversion only occurs in a minority of cases(and, exceptionally,
HBs Seroconversion) and treatment must be prolonged.
Soon after infection, some people experience a brief, flu-like“Seroconversion illness” at the time when antibodies to HIV
are being created.
Interferon treatment may produce an e antigen Seroconversion rate of 37% in genotype A
but only a 6% Seroconversion in type D.
This acute viremia is associated in virtually all people with the activation of CD8+ T cells, which kill HIV-infected cells,
and subsequently with antibody production, or Seroconversion.
The aim is to induce an immune response in patients with chronic hepatitis B by vaccinating them against this virus,
which in theory could either accelerate the natural response(and Seroconversion) or improve the response to treatment.
Interferon treatment may produce an e antigen Seroconversion rate of 37% in genotype A
but only a 6% Seroconversion in type D. Genotype B has similar Seroconversion rates to type A while type C seroconverts only in 15% of cases.